This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Master Pharm Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

0%

Temettü verimi

0%

Ödeme oranı

Sektör ortalama getirisi2.1%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Hisse başına kazançzł0.085
Temettü verim tahmini0%

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Feb 05
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

Dec 13
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

May 25
A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Mar 30
Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

Mar 02
Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Feb 04
I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Jan 08
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Dec 18
Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 27
Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if MPH's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if MPH's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Master Pharm Piyasaya Karşı Temettü Getirisi
MPH temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (MPH)0%
Pazarın Alt %25'i (PL)2.8%
Pazarın En İyi %25'i (PL)7.8%
Sektör Ortalaması (Personal Products)2.1%
Analist tahmini (MPH) (3 yıla kadar)0%

Önemli Temettü: Unable to evaluate MPH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate MPH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: MPH is not paying a notable dividend for the Polish market.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as MPH has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin